SEC Form 4 · accession 0001123292-15-001152
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Franklin M Berger
Director
Period of report
Sep 2, 2015
Accepted (ET)
Sep 4, 2015 · 4:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 2, 2015 | M | 4,065 | $8.49 | A | 57,325 | D | |
| Common Stock | Sep 2, 2015 | M | 4,065 | $7.26 | A | 61,390 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $8.49 | Sep 2, 2015 | M | 4,065 | D | Aug 14, 2011 | Jul 13, 2021 | Common Stock | 4,065 | 0 | D |
| Stock Option (right to buy) | $7.26 | Sep 2, 2015 | M | 4,065 | D | Aug 19, 2013 | Jul 18, 2023 | Common Stock | 4,065 | 0 | D |